Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Peripheral Neurostimulation

5 novembre 2026 aggiornato da: Jean-Louis Horn, Stanford University

Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.

Panoramica dello studio

Stato

Iscrizione su invito

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The investigators wish to understand how electrical stimulation can affect local anesthetic disposition when performing a peripheral nerve block.

By studying this subject, the investigators open possibilities for improvement on many levels:

increasing the efficacy of the nerve block allows for a reduced onset time, reduced incidence of incomplete block, and prolonged duration of the local anesthetics. This allows for patients to fully benefit from the analgesic properties of the nerve block, allows for a decrease in delays for the operating room readiness, and a allows for a decrease in the amount of medication needed for a successful nerve block. This will decrease side effects and risks of the nerve blocks. Overall better post-surgical pain control may decrease risks for developing chronic post-operative pain, a major post-operative complication.

The results of this study will open the door to novel approaches to manage acute post-operative pain.

Tipo di studio

Interventistico

Iscrizione (Stimato)

150

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • California
      • Stanford, California, Stati Uniti, 94305
        • Stanford University Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Undergoing elective upper limb surgery with a planned brachial plexus nerve block

Exclusion Criteria:

  • Under 18 years old
  • ASA score above III
  • Chronic pain condition with daily milligrams of morphine equivalent > 30
  • Poorly controlled psychiatric condition
  • Coagulopathy
  • Active infection
  • Moderate, severe or progressing neuropathy
  • COPD/Chronic oxygen user
  • Pregnancy
  • Incarceration
  • Unable to consent
  • BMI > 35
  • Pacemaker

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Ultrasound-guided brachial plexus block with peripheral nerve stimulation

Patients will receive a brachial plexus catheter with ultrasound guidance as per standard of care, with additional use of the B. Braun HNS 12 nerve stimulator during the loading dose of local anesthesia to maintain a gentle twitch.

Nerve stimulator that is traditionally used for nerve localization during block placements.

Comparatore fittizio: Ultrasound-guided brachial plexus block without peripheral nerve stimulation

Patients will receive the brachial plexus catheter in the same way the first arm would, and the B Braun nerve stimulator will be placed in the same way, but the ground electrode will not be connected to the patient.

Stimulator will be placed and turned on, but the grounding electrode will not be connected to prevent nerve stimulation.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Onset of Motor Block
Lasso di tempo: Within 1 hour after the block placement.

Determining time when patient experiences first symptoms of local anesthetic action on the upper trunk distribution (median or musculo cutaneous nerve)

Within 1 hour after the block placement.
Onset of Sensory Block
Lasso di tempo: Within 1 hour after the block placement.

Determining time when patient experiences first symptoms of local anesthetic action on the superior trunk distribution over the shoulder.

Within 1 hour after the block placement.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Skin Temperature Change
Lasso di tempo: Immediately before and up to 1 hour after neurostimulation and nerve block is performed.

Measuring changes in skin temperature over the course of pre and post stimulation and nerve blocking between the blocked and unblocked arms, measured in degrees Celsius. Using Medline Temperature Sensor.

Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
When Patient Experiences First Pain
Lasso di tempo: up to day 7 post operatively

Time after surgery at which the patient experiences first sign of pain at the surgical site, as measured by the time for first local anesthetic bolus based on pump device history.

up to day 7 post operatively
Time of First Opioid Taken
Lasso di tempo: Within the first 7 days after surgery

As measured by asking patients if they were taking opioids daily after surgery, up to one week.

Within the first 7 days after surgery
Total Post Operative MME/Opioid Usage at Day 1
Lasso di tempo: On Post Operative Day 1

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 1
Total Post Operative MME/Opioid Usage at Day 2
Lasso di tempo: On Post Operative Day 2

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 2
Total Post Operative MME Opioid Usage at Day 3
Lasso di tempo: On Post Operative Day 3

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 3
Total Post Operative MME Opioid Usage at Day 4
Lasso di tempo: On Post Operative Day 4

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 4
Total Post Operative MME Opioid Usage at Day 5
Lasso di tempo: On Post Operative Day 5

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 5
Total Post Operative MME Opioid Usage at Day 6
Lasso di tempo: On Post Operative Day 6

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 6
Opioid Usage Assessment at Day 7
Lasso di tempo: On Post Operative Day 7

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 7
Opioid Usage Assessment at Day 28
Lasso di tempo: On Post Operative Day 28

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 3 weeks and 2) if so, how many pills per day.

On Post Operative Day 28
Opioid Usage Assessment at 6 Months
Lasso di tempo: On Post Operative Month 6

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 5 months and 2) if so, how many pills per day.

On Post Operative Month 6
Opioid Usage Assessment at 1 Year
Lasso di tempo: On Post Operative 1 Year

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 6 months and 2) if so, how many pills per day.

On Post Operative 1 Year
Quality of Recovery
Lasso di tempo: At Post Operative days 7 and 28 , 6 months, and 1 year

Using the standardized -Quality of Recovery 15- at post operative days 7 and 28, 6 months, and 1 year. Each item count on a 0-10 scale where 0 is worst and 10 is best.

PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent]) Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being

PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed

At Post Operative days 7 and 28 , 6 months, and 1 year
General satisfaction
Lasso di tempo: At post operative days 0, 1, 7, 28, 6 months, and 1 year

General satisfaction on a scale from 1-5 (extremely unsatisfied, unsatisfied, neutral, satisfy, extremely satisfied). Asking patients if they would receive the block again (Y/N).

At post operative days 0, 1, 7, 28, 6 months, and 1 year
Adverse Events
Lasso di tempo: Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.

Numbness, Weakness, Tingling, Breathing Difficulties, Hoarseness

Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
Catheter Duration Before Discontinuation
Lasso di tempo: After surgery, up until catheter discontinuation.

Patients' catheter duration before discontinuation, as measured by Avoset pump device data.

After surgery, up until catheter discontinuation.
Total Local Anesthetic Use with Catheter
Lasso di tempo: After surgery, up until catheter discontinuation.

Patients' local anesthetic use with catheter, as measured by Avoset pump device data.

After surgery, up until catheter discontinuation.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

23 luglio 2025

Completamento primario (Stimato)

30 luglio 2027

Completamento dello studio (Stimato)

30 luglio 2027

Date di iscrizione allo studio

Primo inviato

7 agosto 2024

Primo inviato che soddisfa i criteri di controllo qualità

20 agosto 2024

Primo Inserito (Effettivo)

22 agosto 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

10 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

5 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 76523

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

Sì

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .